Mosaic chemotherapy strategies for developing ALS/MND therapeutic approaches: beta-2 adrenergic agonists

Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec:1 Suppl 4:45-53; discussion 53-4.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Research Support, U.S. Gov't, P.H.S.
  • Review

MeSH terms

  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists / therapeutic use*
  • Amyotrophic Lateral Sclerosis / drug therapy*
  • Clenbuterol / therapeutic use*
  • Humans

Substances

  • Adrenergic beta-2 Receptor Agonists
  • Adrenergic beta-Agonists
  • Clenbuterol